CAS 314042-01-8

CID-1067700,2-(3-benzoylthioureido)-5,5-diMethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid

CAS : 314042-01-8

Formule : C₁₈H₁₈N₂O₄S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 390.4765

Ref: IN-DA00C9SW

2-(3-Benzoylthioureido)-5,5-Dimethyl-5,7-Dihydro-4H-Thieno[2,3-C]Pyran-3-Carboxylic Acid

CAS : 314042-01-8

2-(3-Benzoylthioureido)-5,5-Dimethyl-5,7-Dihydro-4H-Thieno[2,3-C]Pyran-3-Carboxylic Acid

Degré de pureté : 98%

Masse moléculaire : 390.48g/mol

Ref: 54-OR1023073

CID-1067700

CAS : 314042-01-8

CID-1067700

Degré de pureté : ≥98%

Masse moléculaire : 390.48g/mol

Ref: 54-BUP02526

CID-1067700

CAS : 314042-01-8

CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).

Formule : C₁₈H₁₈N₂O₄S₂

Degré de pureté : 99.46%

Couleur et forme : Solid

Masse moléculaire : 390.48

Ref: TM-T7558

2-(3-Benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid

CAS : 314042-01-8

Formule : C₁₈H₁₈N₂O₄S₂

Degré de pureté : ≥98%

Masse moléculaire : 390.47

Ref: 10-F547196

CID-1067700

CAS : 314042-01-8

CID-1067700 is a small molecule that is able to inhibit the ubiquitin proteasome system (UPS) and effector proteins. This drug has been shown to be active against wild-type strains of bacteria, such as Mycobacterium tuberculosis. CID-1067700 also inhibits autophagy in mycobacteria, which may be a potential therapeutic target for the treatment of mycobacterial infections. It has been shown to reduce ischemic brain damage in mice and may have therapeutic potential for stroke patients. CID-1067700 binds to the ubiquitin ligase Rsp5 and inhibits its ability to activate transcription factors that regulate cell cycle progression. This inhibition of transcriptional regulation leads to apoptosis, or programmed cell death.

Formule : C₁₈H₁₈N₂O₄S₂

Degré de pureté : Min. 95%

Masse moléculaire : 390.48 g/mol

Ref: 3D-PMA04201